Tara Vijayan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tara Vijayan has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Christina Harris
VA Greater Los Angeles Healthcare System, David Geffen School of Medicine, UCLA, Los Angeles, California, USA
2 shared publications- Kusha Davar
Department of Medicine, Los Angeles General Medical Center , Los Angeles, California
2 shared publications Alice Y. Guh
Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publicationAlison Lydecker
University of Maryland, Baltimore, Baltimore, MD, USA
1 shared publicationAndrea Censullo
Division of Infectious Diseases, Cedars-Sinai Medical Center, University of California, Los Angeles
1 shared publication- Andrew M. Skinner
Research Service and Medicine Section, Veterans Affairs Salt Lake City Healthcare System , Salt Lake City, Utah
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (14) , 4162-4168
Meeting Patients with Hepatitis C Where They Are: Lessons from the HIV Epidemic in the USA
Despite the advent of well-tolerated and curative direct-acting antivirals (DAAs) for hepatitis C virus (HCV), rates of acute HCV infections have increased in the past decade, persistently falling short of national eradication goals. HCV elimination strategies have adopted the care cascade, a framework originating in HIV care, to assess where patients are lost at each step of diagnosis, linkage to care, receipt of DAAs, and achievement of sustained virologic response. Interventions aimed at strengthening the HIV care cascade, including community-based testing, rapid initiation of treatment, and federal funding for treatment and housing, have been instrumental in increasing the number of people living with HIV who achieve viral suppression. Widescale uptake of HCV treatment, meanwhile, continues to face barriers, from payor restrictions to provider hesitance to treat patients who use drugs, despite evidence demonstrating high rates of treatment completion among this population. HIV care has critically reframed treatment nonadherence as a need for more support, rather than as a value judgment and as a reflection of the patient’s ability to receive treatment. We advocate for this approach to be applied to HCV care to provide broader and more equitable access to HCV treatment, and ultimately cure, particularly for marginalized populations such as people who use drugs (PWUD). We propose solutions for increasing HCV treatment uptake using lessons from HIV care, including using a test and treat approach to initiate DAAs during hospital admission.
- 17 August 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (14) , 4162-4168
Open AccessMeeting Patients with Hepatitis C Where They Are: Lessons from the HIV Epidemic in the USA
Despite the advent of well-tolerated and curative direct-acting antivirals (DAAs) for hepatitis C virus (HCV), rates of acute HCV infections have increased in the past decade, persistently falling short of national eradication goals. HCV elimination strategies have adopted the care cascade, a framework originating in HIV care, to assess where patients are lost at each step of diagnosis, linkage to care, receipt of DAAs, and achievement of sustained virologic response. Interventions aimed at strengthening the HIV care cascade, including community-based testing, rapid initiation of treatment, and federal funding for treatment and housing, have been instrumental in increasing the number of people living with HIV who achieve viral suppression. Widescale uptake of HCV treatment, meanwhile, continues to face barriers, from payor restrictions to provider hesitance to treat patients who use drugs, despite evidence demonstrating high rates of treatment completion among this population. HIV care has critically reframed treatment nonadherence as a need for more support, rather than as a value judgment and as a reflection of the patient’s ability to receive treatment. We advocate for this approach to be applied to HCV care to provide broader and more equitable access to HCV treatment, and ultimately cure, particularly for marginalized populations such as people who use drugs (PWUD). We propose solutions for increasing HCV treatment uptake using lessons from HIV care, including using a test and treat approach to initiate DAAs during hospital admission.
- 9 July 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Mixed Nuts, Unsalted.
- 9 July 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Mixed Nuts, Unsalted.
- Open Access
- 21 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (3) , e526-e529
Fosmanogepix Treatment for Coccidioidomycosis Under an Expanded Access Program
Coccidioidomycosis is an invasive fungal infection that can disseminate and cause severe disease. Fosmanogepix (“gepix”), a first-in-class antifungal available via expanded access (NCT06433128), was successful in 8/11 patients (meningitis, 6/8 [75%]; nonmeningeal dissemination, 2/3 [66%]) and was well tolerated for a median treatment duration of 208 days.
- 21 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (3) , e526-e529
Open AccessFosmanogepix Treatment for Coccidioidomycosis Under an Expanded Access Program
Coccidioidomycosis is an invasive fungal infection that can disseminate and cause severe disease. Fosmanogepix (“gepix”), a first-in-class antifungal available via expanded access (NCT06433128), was successful in 8/11 patients (meningitis, 6/8 [75%]; nonmeningeal dissemination, 2/3 [66%]) and was well tolerated for a median treatment duration of 208 days.
- Open Access
- 23 January 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Feeling the Vibes: An Investigation into Resident Antibiotic Prescribing Practices
Background: Efforts to improve inpatient antibiotic prescribing are limited by a lack of insight into the complicated decisions around antibiotic use. We aimed to explore antibiotic therapeutic decision-making among internal medicine (IM) resident physicians. Methods: We performed a qualitative study with a constructivist paradigm employing semi-structured, in-person focus groups of IM trainees at a teaching hospital system from December 2023 through January 2024. Two researchers independently performed a thematic analysis of focus group transcripts. We resolved discrepancies through in-depth discussion and negotiated consensus and converged codes into overarching themes. Results: Twenty-five residents participated across three focus groups. Residents identified a general approach to prescribing empiric antibiotics, including triaging critical illness and identifying: the presence of infection, the source of infection, the antibiotic that covers the likely pathogens, and relevant patient-specific factors. Empiric choice was modulated by three sub-themes: institutional culture, antibiotic stewardship policies, and clinical resources. Major challenges in therapeutic decision-making included navigating uncertainty, fear of clinical deterioration, difficulty determining appropriate antibiotic duration/spectrum, and the inconsistency of clinical reasoning by supervising attendings. Certain safety net strategies were used to mitigate this uncertainty. Residents felt their confidence in antibiotic prescribing decisions improved over time through experience, especially on overnight rotations. Infectious diseases physicians and pharmacists provided education and a needed model approach for therapeutic reasoning and supported residents in increasing their risk tolerance. Conclusion: This study provides insights into resident decision-making regarding antibiotic use, which may inform educational interventions to optimize antibiotic utilization and adherence to practice guidelines at teaching hospitals.
- 23 January 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Open AccessFeeling the Vibes: An Investigation into Resident Antibiotic Prescribing Practices
Background: Efforts to improve inpatient antibiotic prescribing are limited by a lack of insight into the complicated decisions around antibiotic use. We aimed to explore antibiotic therapeutic decision-making among internal medicine (IM) resident physicians. Methods: We performed a qualitative study with a constructivist paradigm employing semi-structured, in-person focus groups of IM trainees at a teaching hospital system from December 2023 through January 2024. Two researchers independently performed a thematic analysis of focus group transcripts. We resolved discrepancies through in-depth discussion and negotiated consensus and converged codes into overarching themes. Results: Twenty-five residents participated across three focus groups. Residents identified a general approach to prescribing empiric antibiotics, including triaging critical illness and identifying: the presence of infection, the source of infection, the antibiotic that covers the likely pathogens, and relevant patient-specific factors. Empiric choice was modulated by three sub-themes: institutional culture, antibiotic stewardship policies, and clinical resources. Major challenges in therapeutic decision-making included navigating uncertainty, fear of clinical deterioration, difficulty determining appropriate antibiotic duration/spectrum, and the inconsistency of clinical reasoning by supervising attendings. Certain safety net strategies were used to mitigate this uncertainty. Residents felt their confidence in antibiotic prescribing decisions improved over time through experience, especially on overnight rotations. Infectious diseases physicians and pharmacists provided education and a needed model approach for therapeutic reasoning and supported residents in increasing their risk tolerance. Conclusion: This study provides insights into resident decision-making regarding antibiotic use, which may inform educational interventions to optimize antibiotic utilization and adherence to practice guidelines at teaching hospitals.
- 15 April 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 80 (6) , 1186-1187
Executive Orders and Caring for Our Transgender Patients
- 15 April 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 80 (6) , 1186-1187
Executive Orders and Caring for Our Transgender Patients
- Open Access
- 8 October 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e168
Informing estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure
Background: Clostridioides difficile infection (CDI) may be misdiagnosed if testing is performed in the absence of signs or symptoms of disease. This study sought to support appropriate testing by estimating the impact of signs, symptoms, and healthcare exposures on pre-test likelihood of CDI. Methods: A panel of fifteen experts in infectious diseases participated in a modified UCLA/RAND Delphi study to estimate likelihood of CDI. Consensus, defined as agreement by >70% of panelists, was assessed via a REDCap survey. Items without consensus were discussed in a virtual meeting followed by a second survey. Results: All fifteen panelists completed both surveys (100% response rate). In the initial survey, consensus was present on 6 of 15 (40%) items related to risk of CDI. After panel discussion and clarification of questions, consensus (>70% agreement) was reached on all remaining items in the second survey. Antibiotics were identified as the primary risk factor for CDI and grouped into three categories: high-risk (likelihood ratio [LR] 7, 93% agreement among panelists in first survey), low-risk (LR 3, 87% agreement in first survey), and minimal-risk (LR 1, 71% agreement in first survey). Other major factors included new or unexplained severe diarrhea (e.g., ≥ 10 liquid bowel movements per day; LR 5, 100% agreement in second survey) and severe immunosuppression (LR 5, 87% agreement in second survey). Conclusion: Infectious disease experts concurred on the importance of signs, symptoms, and healthcare exposures for diagnosing CDI. The resulting risk estimates can be used by clinicians to optimize CDI testing and treatment.
- 8 October 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e168
Open AccessInforming estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure
Background: Clostridioides difficile infection (CDI) may be misdiagnosed if testing is performed in the absence of signs or symptoms of disease. This study sought to support appropriate testing by estimating the impact of signs, symptoms, and healthcare exposures on pre-test likelihood of CDI. Methods: A panel of fifteen experts in infectious diseases participated in a modified UCLA/RAND Delphi study to estimate likelihood of CDI. Consensus, defined as agreement by >70% of panelists, was assessed via a REDCap survey. Items without consensus were discussed in a virtual meeting followed by a second survey. Results: All fifteen panelists completed both surveys (100% response rate). In the initial survey, consensus was present on 6 of 15 (40%) items related to risk of CDI. After panel discussion and clarification of questions, consensus (>70% agreement) was reached on all remaining items in the second survey. Antibiotics were identified as the primary risk factor for CDI and grouped into three categories: high-risk (likelihood ratio [LR] 7, 93% agreement among panelists in first survey), low-risk (LR 3, 87% agreement in first survey), and minimal-risk (LR 1, 71% agreement in first survey). Other major factors included new or unexplained severe diarrhea (e.g., ≥ 10 liquid bowel movements per day; LR 5, 100% agreement in second survey) and severe immunosuppression (LR 5, 87% agreement in second survey). Conclusion: Infectious disease experts concurred on the importance of signs, symptoms, and healthcare exposures for diagnosing CDI. The resulting risk estimates can be used by clinicians to optimize CDI testing and treatment.
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 150-154
Case Report: Cardiovascular Manifestations due to Flea-Borne Typhus
: Flea-borne typhus is a vector-borne disease caused by Rickettsia typhi that occurs worldwide, except in Antarctica. In the United States, most cases are restricted to California, Hawaii, and Texas. The syndrome is characterized by nonspecific signs and symptoms: fever, headache, rash, arthralgia, cough, hepatosplenomegaly, diarrhea, and abdominal pain. Although flea-borne typhus can cause pulmonary, neurological, and renal complications, the cardiovascular system is rarely affected. We present a case of endocarditis resulting from flea-borne typhus diagnosed by blood microbial cell-free DNA testing that required valve replacement and antibiotic therapy for 6 months. In addition, we review 20 cases of presumed and confirmed cardiovascular manifestations resulting from flea-borne typhus in the literature.
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 150-154
Case Report: Cardiovascular Manifestations due to Flea-Borne Typhus
: Flea-borne typhus is a vector-borne disease caused by Rickettsia typhi that occurs worldwide, except in Antarctica. In the United States, most cases are restricted to California, Hawaii, and Texas. The syndrome is characterized by nonspecific signs and symptoms: fever, headache, rash, arthralgia, cough, hepatosplenomegaly, diarrhea, and abdominal pain. Although flea-borne typhus can cause pulmonary, neurological, and renal complications, the cardiovascular system is rarely affected. We present a case of endocarditis resulting from flea-borne typhus diagnosed by blood microbial cell-free DNA testing that required valve replacement and antibiotic therapy for 6 months. In addition, we review 20 cases of presumed and confirmed cardiovascular manifestations resulting from flea-borne typhus in the literature.
- Open Access
- 4 October 2023
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 78 (3) , 501-502
What Did I Miss?
Tara Vijayan, MD, MPH; What Did I Miss?, Clinical Infectious Diseases, , ciad572, https://doi.org/10.1093/cid/ciad572
- 4 October 2023
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 78 (3) , 501-502
Open AccessWhat Did I Miss?
Tara Vijayan, MD, MPH; What Did I Miss?, Clinical Infectious Diseases, , ciad572, https://doi.org/10.1093/cid/ciad572
- 1 July 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (7) , 985-986
Achieving Equity in Residency and Fellowship Applications With a Partial Blindfold: A Call for Measuring the Distance Traveled
- 1 July 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (7) , 985-986
Achieving Equity in Residency and Fellowship Applications With a Partial Blindfold: A Call for Measuring the Distance Traveled
- Open Access
- 6 May 2023
- Published by Springer Nature in BMC Medical Education
- Vol. 23 (1) , 1-7
The PEST (Pathology, Epidemiology, Severity, Treatment) approach to optimizing antimicrobial therapy
Background: Selecting an empiric antimicrobial regimen can be difficult for early learners and misuse of antibiotics can lead to adverse events and antimicrobial resistance. There have been few interventions that have focused on improving antibiotic decision making, as a form of therapeutic reasoning, for post-graduate trainees. We describe here an approach to aid internal medicine interns in their therapeutic reasoning, particularly when it comes to diagnosing and empirically treating infections. Methods: The PEST (pathology, epidemiology, severity, treatment) model was created as a four-step approach to therapeutic reasoning and choosing an appropriate antimicrobial regimen for a given infectious disease syndrome. In February 2020, we conducted two independent teaching sessions for interns on the PEST approach. We assessed pre-and post-teaching responses to five clinical vignette-based questions. Results were presented as a percentage of interns who chose an appropriate antibiotic and provided sufficient therapeutic reasoning as defined by using at least three out of the four PEST criteria. Statistical analysis occurred via Fischer’s exact test to determine the level of statistical significance between responses. Results: Twenty-seven interns participated in the activity. At baseline, several interns had incorporated aspects of the PEST approach in their pre-teaching responses. Ten interns commented on the usefulness of such a systematic approach. While there was no statistically significant difference in antibiotic selection, the teaching session demonstrated a trend towards significance in improving therapeutic reasoning as defined by the PEST strategy. Conclusion: Our results suggested an improvement in using a structured cognitive tool such as the PEST approach to reinforce therapeutic reasoning, but the method did little to improve antibiotic selection. Some interns used select “PEST” concepts prior to the intervention suggesting that the PEST approach may enhance prior knowledge or clinical reasoning skills. Continued incorporation of the PEST approach using a case-based framework may solidify conceptual and practical knowledge of antimicrobial selection. Further studies are needed to assess the impact of such teaching interventions.
- 6 May 2023
- Published by Springer Nature in BMC Medical Education
- Vol. 23 (1) , 1-7
Open AccessThe PEST (Pathology, Epidemiology, Severity, Treatment) approach to optimizing antimicrobial therapy
Background: Selecting an empiric antimicrobial regimen can be difficult for early learners and misuse of antibiotics can lead to adverse events and antimicrobial resistance. There have been few interventions that have focused on improving antibiotic decision making, as a form of therapeutic reasoning, for post-graduate trainees. We describe here an approach to aid internal medicine interns in their therapeutic reasoning, particularly when it comes to diagnosing and empirically treating infections. Methods: The PEST (pathology, epidemiology, severity, treatment) model was created as a four-step approach to therapeutic reasoning and choosing an appropriate antimicrobial regimen for a given infectious disease syndrome. In February 2020, we conducted two independent teaching sessions for interns on the PEST approach. We assessed pre-and post-teaching responses to five clinical vignette-based questions. Results were presented as a percentage of interns who chose an appropriate antibiotic and provided sufficient therapeutic reasoning as defined by using at least three out of the four PEST criteria. Statistical analysis occurred via Fischer’s exact test to determine the level of statistical significance between responses. Results: Twenty-seven interns participated in the activity. At baseline, several interns had incorporated aspects of the PEST approach in their pre-teaching responses. Ten interns commented on the usefulness of such a systematic approach. While there was no statistically significant difference in antibiotic selection, the teaching session demonstrated a trend towards significance in improving therapeutic reasoning as defined by the PEST strategy. Conclusion: Our results suggested an improvement in using a structured cognitive tool such as the PEST approach to reinforce therapeutic reasoning, but the method did little to improve antibiotic selection. Some interns used select “PEST” concepts prior to the intervention suggesting that the PEST approach may enhance prior knowledge or clinical reasoning skills. Continued incorporation of the PEST approach using a case-based framework may solidify conceptual and practical knowledge of antimicrobial selection. Further studies are needed to assess the impact of such teaching interventions.